Last verified · v1.0

Calculator · health

Timi Risk Score For Ua/Nstemi Calculator

Calculates the 7-variable TIMI Risk Score for UA/NSTEMI, stratifying acute coronary syndrome patients into low, intermediate, and high 14-day MACE risk categories.

FreeInstantNo signupOpen source

Inputs

Age ≥ 65 years

≥3 CAD risk factors

Known CAD (stenosis ≥50%)

ASA use in past 7 days

Severe angina (≥2 episodes in 24h)

ST deviation ≥0.5 mm on EKG

Positive cardiac marker

TIMI Risk Score (0-7)

—

Get a plain-English breakdown of your result with practical next steps.

TIMI Risk Score (0-7)—points

The formula

How the
result is
computed.

What Is the TIMI Risk Score for UA/NSTEMI?

The TIMI Risk Score for Unstable Angina (UA) and Non-ST-Elevation Myocardial Infarction (NSTEMI) is a validated clinical decision tool that stratifies patients with acute coronary syndromes (ACS) into low, intermediate, and high-risk categories. Originally developed by Antman EM et al. and published in JAMA 2000;284(7):835-842, the score assigns one point for each of seven independent risk predictors, producing a composite integer from 0 to 7. Emergency physicians and cardiologists rely on this timi ua nstemi calculator to guide decisions about early invasive strategies, anticoagulation intensity, and hospital disposition.

The TIMI Scoring Formula

The formula sums seven binary variables, each contributing equally to the total. No single variable carries greater weight than another.

TIMI Score = x1 + x2 + x3 + x4 + x5 + x6 + x7

where each variable equals 1 if the clinical criterion is met and 0 if absent. The resulting score ranges from 0 (lowest risk) to 7 (highest risk).

The Seven Risk Variables Explained

Age 65 years or older: Advanced age is a well-established independent predictor of adverse cardiovascular outcomes. Patients aged 65 and older score 1 point.
Three or more CAD risk factors: Hypertension, hypercholesterolemia, diabetes mellitus, family history of coronary artery disease, or active cigarette smoking — any three present qualifies for 1 point.
Known CAD (prior stenosis 50% or greater): Documented coronary stenosis of at least 50% on prior angiography indicates established atherosclerotic burden and earns 1 point.
Aspirin use in the past 7 days: Recent ASA use paradoxically signals a higher-risk patient who may be aspirin-resistant or whose disease progresses despite antiplatelet therapy. Score 1 point.
Severe angina (two or more episodes in 24 hours): Two or more ischemic episodes within the preceding 24 hours suggest unstable plaque dynamics. Score 1 point.
ST-segment deviation 0.5 mm or greater on EKG: Horizontal or downsloping ST depression, or transient ST elevation of at least 0.5 mm on the presenting electrocardiogram, scores 1 point and indicates active ischemia.
Positive cardiac biomarker: Elevation of troponin I, troponin T, or CK-MB above the 99th-percentile upper reference limit confirms myocardial necrosis and scores 1 point.

Interpreting Your TIMI Score: 14-Day Risk Estimates

The original TIMI IIIB trial data link each integer score to the 14-day composite outcome of all-cause mortality, new or recurrent MI, or urgent revascularization:

Score 0-1: approximately 4.7% event rate — Low risk. Conservative management with close outpatient follow-up is often appropriate.
Score 2: approximately 8.3% event rate — Low-intermediate risk. Monitoring and repeat biomarker testing are recommended.
Score 3: approximately 13.2% event rate — Intermediate risk. Cardiology consultation and consideration of early invasive strategy are warranted.
Score 4: approximately 19.9% event rate — Intermediate-high risk. Early catheterization and potent antiplatelet therapy are typically indicated.
Score 5: approximately 26.2% event rate — High risk. Urgent invasive strategy and aggressive medical therapy are strongly recommended.
Score 6-7: approximately 40.9% event rate — Very high risk. Immediate consultation for emergent revascularization is indicated.

Real-World Clinical Example

Consider a 68-year-old male (1 point: age 65 or older) with hypertension, diabetes, and a family history of CAD (1 point: three or more risk factors) who presents with chest pain after taking daily aspirin for two weeks (1 point: ASA use within 7 days). His presenting EKG shows 1 mm ST depression in leads V4-V6 (1 point: ST deviation), and troponin I returns at 0.08 ng/mL above the institutional 99th-percentile limit (1 point: positive biomarker). His TIMI score totals 5, placing him in the high-risk category with an estimated 26.2% risk of adverse events within 14 days — a strong indication for urgent cardiology consultation and early catheterization.

Methodology and Validation

The TIMI Risk Score was derived from the TIMI IIIB randomized trial, which enrolled 1,957 patients with UA or NSTEMI between 1989 and 1992. Antman EM et al. identified the seven predictors through multivariate logistic regression analysis, with findings published in JAMA (2000). External validation studies, including a systematic review published in PMC (2023), confirm that the score maintains adequate discriminatory ability with AUC values of 0.62-0.65 across diverse patient populations. The official TIMI Study Group continues to maintain updated calculators and publish ongoing research. Clinicians must integrate this score with full clinical judgment, hemodynamic status, imaging findings, and institutional protocols for optimal decision-making.

Reference

Frequently asked questions

What does a TIMI score of 5 indicate for a patient with unstable angina?

A TIMI score of 5 places a patient in the high-risk category for UA/NSTEMI. According to the original Antman et al. JAMA 2000 derivation study, a score of 5 corresponds to approximately a 26.2% rate of all-cause mortality, new myocardial infarction, or urgent revascularization within 14 days. Clinical evidence strongly supports early invasive coronary angiography combined with aggressive antiplatelet and anticoagulant therapy for these patients without delay.

How does the TIMI UA/NSTEMI score differ from the HEART score?

The TIMI UA/NSTEMI score uses seven binary variables totaling 0-7, designed specifically for patients already diagnosed with ACS to predict 14-day MACE risk. The HEART score assesses History, ECG, Age, Risk factors, and Troponin across all undifferentiated chest pain presentations to predict 6-week risk. Both tools achieve comparable AUC values of approximately 0.62-0.68 in external validation studies but serve slightly different clinical entry points and patient populations in emergency settings.

What TIMI score threshold should prompt early invasive cardiac management?

ACC/AHA guidelines and the original TIMI derivation data support early invasive evaluation for patients with a TIMI score of 3 or higher. Scores of 4 and above — corresponding to 14-day event rates of 19.9% to 40.9% — indicate high or very high risk. For these patients, urgent cardiac catheterization, glycoprotein IIb/IIIa inhibitors, and intensified anticoagulation are backed by robust clinical trial evidence. Scores below 3 may support a conservative initial strategy with close monitoring.

Why does recent aspirin use paradoxically increase the TIMI risk score?

Aspirin use within the past 7 days is counterintuitive as a risk predictor but reflects an important clinical reality. Patients on ASA therapy who still develop ACS likely have more refractory or advanced coronary artery disease, possible aspirin resistance, or more active plaque instability than ASA-naive patients. The original TIMI multivariate logistic regression analysis found that prior ASA use independently predicted worse 14-day outcomes regardless of all other clinical variables present in the model.

How accurate is the TIMI risk score at predicting major adverse cardiac events?

The TIMI UA/NSTEMI score demonstrates moderate discriminatory accuracy, with area under the curve (AUC) values typically between 0.62 and 0.65 in external validation cohorts. A 2023 systematic review published in PMC confirmed this performance across multiple diverse patient populations. While not highly precise at the individual level, the score reliably identifies the high-risk tail — scores 5 to 7 — that derives the greatest benefit from early invasive intervention, making it a clinically actionable tool for emergency triage decisions.

Can the TIMI UA/NSTEMI calculator be applied to patients with STEMI?

No. The TIMI Risk Score for UA/NSTEMI applies exclusively to patients without persistent ST elevation. A separate scoring tool — the TIMI Risk Score for STEMI — uses entirely different variables including anterior ST elevation location, heart rate, systolic blood pressure, Killip class, and body weight to estimate 30-day mortality risk. Applying the UA/NSTEMI calculator to STEMI patients produces inaccurate risk estimates and could lead to inappropriate clinical management decisions with potentially serious patient safety consequences.